Nnamdi Ikemefuna Okafor | Pharmaceutical Development | Research Excellence Award

Published on by Top Pharmaceutical

Research Excellence Award

Nnamdi Ikemefuna Okafor –Β University of the Witwatersrand

Nnamdi Ikemefuna Okafor
Affiliation University of the Witwatersrand
Country South Africa
Scopus ID 57211213082
Documents 15
Citations 145
h-index 6
Subject Area Pharmaceutical Development
Event International Top Pharmaceutical Awards
ORCID 0000-0003-3104-9977

Nnamdi Ikemefuna Okafor is a pharmaceutical researcher affiliated with the University of the Witwatersrand, South Africa. His academic work focuses on pharmaceutical development, advanced drug delivery systems, nanomedicine, and pharmaceutical formulation. His research explores innovative approaches to improving therapeutic delivery, drug solubility, formulation performance, and biomedical applications. His scholarly contributions demonstrate engagement with contemporary challenges in pharmaceutical sciences and translational drug development.[1][2]

1. Abstract

Nnamdi Ikemefuna Okafor’s research addresses pharmaceutical formulation, nanotechnology-based therapeutics, and advanced drug delivery. His publications examine liposomal drug delivery, nanoparticle functionalization, microencapsulation, and formulation strategies for improving the pharmaceutical properties of therapeutic compounds. These research directions contribute to ongoing scientific discussions concerning drug bioavailability, targeted delivery, pediatric formulations, and the development of improved therapeutic systems.[3][4]

2. Keywords

Pharmaceutical Development; Drug Delivery Systems; Nanomedicine; Pharmaceutical Formulation; Liposomes; Nanoparticles; Microencapsulation; Pharmaceutical Technology; Targeted Drug Delivery; Biomedical Research.

3. Introduction

Pharmaceutical development integrates formulation science, drug characterization, and innovative delivery technologies to address limitations associated with conventional medicines. Okafor’s scholarly interests align with these objectives through investigations involving nanocarriers, pharmaceutical materials, and therapeutic formulation. His work explores scientific approaches that may improve drug administration and support the development of more effective pharmaceutical products.[3][5]

4. Research Profile

His research profile reflects interdisciplinary engagement across pharmaceutics, pharmaceutical technology, nanomedicine, and drug delivery. His reported institutional affiliation is the University of the Witwatersrand in South Africa. His ORCID record, identified as 0000-0003-3104-9977, provides an additional researcher identification reference for connecting his scholarly activities and publications.[1][2]

5. Research Contributions

His contributions also extend to functionalized polydopamine nanoparticles and their potential applications in therapeutic delivery. Research examining nanoparticle-based approaches for tuberculosis treatment highlights the importance of functionalization, drug delivery efficiency, and innovative nanomaterials. These investigations connect pharmaceutical nanotechnology with infectious disease research and emerging therapeutic strategies.[4]

6. Publications

His publication record includes research on microencapsulation techniques in HIV pediatric formulations, discussing formulation challenges and approaches for improving medicine delivery in children. This work contributes to pharmaceutical research addressing therapeutic accessibility, dosage formulation, and the development of appropriate drug delivery technologies.[5]

7. Research Impact

The supplied Scopus profile information reports 15 documents, 145 citations, and an h-index of 6. These indicators provide quantitative information about his indexed scholarly output and citation activity. His publications demonstrate relevance to pharmaceutical formulation, drug delivery technologies, nanomedicine, and therapeutic development. Continued interdisciplinary research and broader scientific collaboration may further strengthen the visibility and application of his contributions.

8. Award Suitability

Okafor’s research activities demonstrate alignment with the objectives of the Research Excellence Award presented through the International Top Pharmaceutical Awards. His work across advanced drug delivery, nanomedicine, pharmaceutical formulation, and therapeutic development represents relevant contributions to contemporary pharmaceutical sciences. His documented publications and reported research indicators provide a basis for considering his academic contributions within this recognition category.[5]

9. Conclusion

Nnamdi Ikemefuna Okafor demonstrates an active research profile in pharmaceutical development and advanced drug delivery. His publications address relevant challenges in nanomedicine, liposomal formulations, and therapeutic delivery systems. These contributions provide a foundation for continued research in pharmaceutical innovation and support his consideration for the Research Excellence Award under the International Top Pharmaceutical Awards.

11. References

  1. Elsevier. (n.d.). Scopus author details: Nnamdi Ikemefuna Okafor, Author ID 57211213082. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57211213082
  2. Okafor, N. I., & Nnaji, N. J. (2025). The Preparation of Abacavir-Loaded Liposomes for Improved Drug Solubility and Dissolution Rate. Pharmaceutical Chemistry Journal, 59(2), 241–257.
    DOI: https://doi.org/10.1007/s11094-025-03385-1
  3. Okafor, N. I., Nnaji, P., Nnolum-Orji, N. F., & Choonara, Y. E. (2025). Functionalized Polydopamine Nanoparticles: A Promising Drug Delivery Platform for the Treatment of Tuberculosis. Drug Development Research.
    DOI: https://doi.org/10.1002/ddr.70109
  4. Okafor, N. I., & Mudigonda, K. (2024). Microencapsulation Techniques in HIV Pediatric Formulations: Advances and Future Outlook. Advances in Pharmacological and Pharmaceutical Sciences, 2024, 5081655.
    DOI: https://doi.org/10.1155/2024/5081655
  5. Okafor, N. I., & Nnaji, N. J. (2024). Liposomes, Facilitating the Encapsulation and Improved Solubility of Zidovudine Antiretroviral Drug. BioNanoScience, 14, 4877–4894.
    DOI: https://doi.org/10.1007/s12668-024-01504-y

Shanthi Veerappapillai | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Shanthi Veerappapillai | Drug Discovery and Development | Best Researcher Award

Dr Shanthi Veerappapillai, Vellore Institute of Technology, India

Dr. Shanthi Veerappapillai is a distinguished Professor at VIT University, specializing in Bioinformatics and Computational Biology. With a Ph.D. from VIT, her research interests include computational protein analysis, drug resistance studies, and virtual screening, particularly focusing on infectious diseases like HIV and tuberculosis. She has led multiple funded research projects and published over 130 peer-reviewed articles. Dr. Veerappapillai has been recognized with awards like the Women Achiever Award for Sponsored Research Excellence (2020) and has supervised numerous Ph.D. graduates. Her dedication to education and research is also reflected in her active participation in conferences and professional societies. πŸ‘©β€πŸ”¬πŸ“šπŸ’»πŸŒ

Publication Profile

Google Scholar

Education Qualification

Dr. Shanthi Veerappapillai holds a Ph.D. in Bioinformatics from VIT University, Tamil Nadu, India, and an M.Tech in Chemical Process and Design from SASTRA University, Tamil Nadu, India. She also earned a B.Tech in Chemical Engineering from EGS Pillai Engineering College, Bharathidasan University, Tamil Nadu, India. With a strong foundation in both chemical engineering and bioinformatics, Dr. Veerappapillai brings a multidisciplinary approach to her research and academic work. Her diverse academic background equips her with the expertise to bridge the gap between technology and biology, contributing to advancements in various scientific fields. πŸ§¬βš™οΈπŸŽ“

Leadership in Research

Dr. Shanthi Veerappapillai is a dedicated scientist with extensive leadership experience as Principal Investigator (PI) in multiple prominent projects. Her research spans critical areas such as drug repurposing strategies and cancer research, showcasing her expertise in advancing both medical and computational biology. Through her work, she has contributed significantly to the development of innovative therapeutic approaches, emphasizing her commitment to enhancing healthcare and medical research. Her ability to lead and collaborate on large-scale projects underscores her impact in the field, making her a valuable asset in shaping the future of medical science and computational biology. πŸ§¬πŸ”¬πŸ’Š

Mentorship and Teaching

Dr. Shanthi Veerappapillai is a distinguished academic with vast experience in supervising successful Ph.D. candidates and teaching specialized subjects in biotechnology and bioinformatics. Her dedication to fostering academic development is evident in her role as a mentor to future researchers. With a passion for guiding students through advanced research topics, she has contributed significantly to shaping the next generation of experts in her field. Her work in biotechnology and bioinformatics continues to inspire students, encouraging innovation and critical thinking in these dynamic disciplines. πŸ‘©β€πŸ”¬πŸ“šπŸŽ“πŸ”¬πŸ‘©β€πŸ’»

Community Engagement

Dr. Shanthi Veerappapillai is a dedicated academician who has made significant contributions to the scientific community through her active involvement in organizing conferences and workshops. As a member of various professional bodies, Dr. Veerappapillai continuously strengthens her presence in the academic world, sharing her expertise and collaborating with fellow researchers. Her commitment to advancing knowledge and fostering professional connections has had a lasting impact on her field. With a focus on promoting growth in the academic and scientific community, Dr. Veerappapillai’s efforts continue to inspire others. πŸŒπŸ§‘β€πŸ«πŸ“š

Awards and Achievement

Dr. Shanthi Veerappapillai is a distinguished researcher with 131 peer-reviewed journal articles and an H-index of 14. She received the Best Chapter Award from BRSI-VIT for her exceptional contributions in 2023. She was honored with the Women Achiever Award for Sponsored Research Excellence in 2020 and has been a Research Fellow at INTI International University, Malaysia since June 2023. Dr. Veerappapillai’s academic journey includes producing 100% results in Chemical Engineering Thermodynamics courses and securing university ranks and prizes for academic excellence. She has also received several accolades, including a Best Poster Presentation Award at VIT University. πŸ†πŸ“šπŸ‘©β€πŸ”¬πŸŒŸ

Research Focus

Dr. V. Shanthi’s research primarily focuses on molecular simulation, bioinformatics, and computational approaches to drug discovery. She has explored mechanisms of drug resistance, particularly in influenza virus neuraminidase, using molecular simulations to understand oseltamivir resistance. Her work also spans polypharmacology, investigating therapeutic agents for non-small cell lung cancer, and the identification of potential inhibitors for various viruses like H5N1. Additionally, she has contributed to bioprocess industry applications, drug repurposing, and plant-based therapeutic compounds. Her research aims at enhancing drug design, discovering novel therapeutic agents, and understanding the molecular interactions that govern drug efficacy. πŸ”¬πŸ’ŠπŸ¦ πŸ’‘

Publication Top Notes

Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach

Current progress and future perspectives of polypharmacology: From the view of non-small cell lung cancer

Bioactive Amento flavone isolated fromΒ Cassia fistulaΒ L. leaves exhibits therapeutic efficacy

Application of heat exchangers in bioprocess industry: a review

Multi-dimensional screening strategy for drug repurposing with statistical frameworkβ€”a new road to influenza drug discovery

Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach

Role of the cation-Ο€ interaction in therapeutic proteins: A comparative study with conventional stabilizing forces

 

 

 

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Mr Victor Ajayi, University of Medical sciences Ondo Nigeria, Nigeria

Mr. Oluwadamilola Victor Ajayi is a distinguished academic and researcher in human physiology 🧬, with a B.Tech, M.Sc., and M.Phil. from reputable institutions. His groundbreaking research focuses on anti-ulcerogenic and antioxidant effects, phytochemical profiling, and bioactive compounds’ therapeutic roles 🩺. With over a decade of teaching experience at UNIMED πŸŽ“, he excels in curriculum development and research mentorship. A member of esteemed bodies like PSN and Physoc πŸ…, Mr. Ajayi actively engages in advancing physiology through publications and conferences. His dedication to science and education makes him a standout contributor in his field 🌍.

Publication Profile

orcid

Educational Backgrounds

Victor Ajayi’s academic journey spans several prestigious institutions. He is currently pursuing an M.Phil in Human Physiology at the Federal University of Technology, Akure (FUTA), starting in November 2024. He previously attended the University of Medical Sciences (UNIMED), Ondo, from August 2022 to December 2024, and earned his M.Sc. in Human Physiology from the University of Ibadan in November 2018. Victor completed his B.Tech in Human Physiology at Ladoke Akintola University of Technology (LAUTECH) in November 2011. His earlier academic milestones include WAEC (2009) and NECO (2002). πŸŽ“πŸ“šπŸ‘¨β€πŸŽ“

Work Experience

Victor Ajayi has a diverse work experience spanning various roles in academia and healthcare. He started with industrial training as a Technologist at Spring Specialist Hospital in 2010, followed by NYSC at Ondo State School of Nursing, where he taught Physiology and Anatomy. Victor later worked as a teacher and guest tutor at different institutions, including Integrity Nursery, Ondo State School of Nursing, and several colleges. At the University of Medical Sciences, he serves as an Assistant Lecturer, course coordinator, and level adviser, while also supervising graduate students. His contributions to Physiology education remain invaluable. πŸ₯πŸ“šπŸ‘¨β€πŸ«

Membership

Mr. Victor Ajayi D. is an active member of esteemed professional bodies such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc). Over the years, he has attended several notable conferences and workshops, including the 28th and 29th Scientific Conferences of PSN at the University of Ilorin in 2008 and 2009, and the 31st conference at Lagos State University in 2011. He also participated in workshops on pedagogy, effective communication, animal ethics, and integrated registration. His dedication to continued learning is evident in his certified seminar attendance, such as the Bioinformatics and Genomics course in October 2024. πŸ“šπŸ”¬πŸ§‘β€πŸ«

Community and Professional Engagement

Mr. Victor Ajayi has consistently showcased remarkable leadership in professional communities. As a dedicated member of esteemed organizations such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc), he has made significant contributions to the advancement of his field. His active participation in numerous conferences and workshops underscores his commitment to continuous learning and staying at the forefront of his profession. Through these engagements, Mr. Ajayi has demonstrated a passion for professional growth and a commitment to fostering collaboration within the scientific community. His involvement continues to inspire and influence others in the field. πŸ’ΌπŸ“š

Accolades and Recognition

Mr. Victor Ajayi has made significant contributions to research, education, and professional development, positioning him as a strong contender for the Best Researcher Award. Although his CV does not highlight specific prior awards, his innovative approaches to addressing physiological challenges and his commitment to advancing scientific knowledge demonstrate his potential. Additionally, his dedication to mentoring the next generation of researchers reflects his passion for nurturing talent and fostering academic growth. Mr. Ajayi’s work continues to inspire and impact the research community, showcasing his outstanding ability to drive change and innovation in his field. πŸ†πŸ“šπŸ”¬

Research Focus

Mr. Victor Ajayi’s research focuses on the anti-inflammatory and anti-oxidative effects of pasteurized yoghurt in mitigating gastric ulceration induced by indomethacin in male Wistar rats. This study delves into gastrointestinal health and the potential therapeutic benefits of food-based interventions in inflammatory conditions. His work contributes to pharmacology, nutritional science, and biomedical research with an emphasis on how diet and natural substances can influence disease progression and provide alternative treatments. This aligns with the field of Pharmacological Toxicology and Gastroenterology, exploring the intersection of nutrition and pharmacology in disease management. πŸ§‘β€βš•οΈπŸ½οΈπŸ’Š

Publication Top Notes

Anti-inflammatory and anti-oxidative effect of pasterurised yoghurt in indomethacin induced gastric ulceration in male Wistar rats